Gilles Divita

This inventor holds 20 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Intracellular Delivery. Top assignees: Aadigen, LLC, Centre National De La Recherche Scientifique, Affymetrix, Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Divita. Retrieved from https://idiyas.com/inventor/gilles-divita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 11)

% Patents Active = 85.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 19)

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 393(Granted Patents)

Location History:

Paris, FR (2005)
Villeurbanne, FR (2010)
Mauguio, FR (2009 - 2019)
Saint-Andre-de-Sangonis, FR (2018 - 2020)
St André de Sangonis, FR (2019 - 2023)

Company Filing History:

Centre National De La Recherche Scientifique

Centre De La Recherche De La Scientifique

patent

6. 1 out of 1

Centre National De Larecherche De La Recherche

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Peptides

Nanoparticles

Cell Penetrating Peptides

Intracellular Delivery

siRNA Delivery

Antiviral Peptides

Peptide Carriers

Transfection Agents

Mammalian Cells

Methods

Compositions

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357695 - Peptides and nanoparticles for intracellular delivery of molecules (2025-07-15),

2. 11713336 - Peptides and nanoparticles for intracellular delivery of molecules (2023-08-01),

3. 10745440 - Peptides and nanoparticles for intracellular delivery of molecules (2020-08-18),

4. 10688194 - Cell penetrating peptides for intracellular delivery of molecules (2020-06-23),

5. 10421784 - Cell penetrating peptides for intracellular delivery of molecules (2019-09-24),

6. 10287581 - Cell penetrating peptides for intracellular delivery of molecules (2019-05-14),

7. 10189876 - Cell penetrating peptides for intracellular delivery of molecules (2019-01-29),

8. 10118944 - Cell penetrating peptides for intracellular delivery of molecules (2018-11-06),

9. 10111965 - Cell penetrating peptides for intracellular delivery of molecules (2018-10-30),

10. 9834581 - Cell penetrating peptides for intracellular delivery of molecules (2017-12-05),

11. 9598465 - Cell penetrating peptides for intracellular delivery of molecules (2017-03-21),

12. 9579395 - Cell penetrating peptides for intracellular delivery of molecules (2017-02-28),

13. 9376468 - Cell penetrating peptides for intracellular delivery of molecules (2016-06-28),

14. 8354387 - Methods and compositions for delivering siRNA into mammalian cells (2013-01-15),

15. 8242081 - Cell penetrating peptides for intracellular delivery of molecules (2012-08-14),

Title: Innovations by Gilles Divita: A Pioneer in Molecular Delivery

Introduction

Gilles Divita, based in Mauguio, France, is a distinguished inventor known for his groundbreaking contributions to the field of molecular delivery. With an impressive portfolio of 19 patents, he has made significant strides in the development of peptides and nanoparticles that enhance intracellular delivery of various cargo molecules, including nucleic acids.

Latest Patents

Among his latest innovations, Divita has focused on the creation of peptides and peptide-containing complexes/nanoparticles specifically designed for stabilizing and delivering cargo molecules. His groundbreaking inventions in this area are aimed at improving the efficiency and effectiveness of molecular delivery systems, making them viable for various applications in biotechnology and medicine.

Career Highlights

Divita has had a remarkable career, working with notable companies such as Aadigen, LLC and the Centre National de la Recherche Scientifique. His work in these institutions has been pivotal in advancing research and development efforts in the field of molecular biology and drug delivery systems.

Collaborations

Throughout his career, Gilles has had the opportunity to collaborate with talented coworkers including May Catherine Morris and Karidia Konate. These partnerships have not only enhanced his work but have also contributed to the broader scientific community, fostering innovation and collaboration in the development of new technologies.

Conclusion

Gilles Divita’s contributions to the field of molecular delivery highlight his role as a significant innovator. Through his patents and collaborations, he continues to push the boundaries of what is possible in the delivery of complex biological molecules, paving the way for new therapeutic approaches and technologies in healthcare. His continued work promises to yield valuable advancements that could potentially transform treatment methodologies in the future.

Profile summary based on public USPTO records.